Word

KLARIFY

Status

Pending

Status Code

654

Status Date

Friday, March 8, 2024

Serial Number

79975813

Mark Type

5

Filing Date

Friday, February 11, 2022

Trademark Owner History

ALK-Abelló A-S

Classifications

9 computer software, namely downloadable computer software for medical use for assisting allergy and asthma patients and medical personnel in storing and handling patient data; diagnostic apparatus for testing food, namely, for mold detection; optical sensors for detecting and analyzing the presence of chemicals, toxins, mold and allergens in food, food components and food products; downloadable electronic publications in the nature of magazines and periodicals in the field of allergy and asthma; downloadable electronic magazines and periodicals in the field of allergy and asthma; online downloadable electronic questionnaires on medical issues relating to allergy and asthma; none of the aforesaid goods relating to the cardiovascular field nor for use in continence management, but all solely for use in relation to allergy and asthma

38 Providing access, with or without subscription, to an e-commerce platform on the Internet giving users access to medical information in the allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic disease as well as atopic dermatitis and food allergy fields, namely, providing access to telecommunication networks; none of the aforesaid services in relation to the cardiovascular field nor in relation to continence management, but all in relation to allergy and asthma only

5 Pharmaceutical and veterinary preparations for immunotherapeutic purposes for the treatment of autoimmune diseases; pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; diagnostic preparations for medical purposes, diagnostic reagents and diagnostic testing strips for medical use in the field of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; eye drops; nose drops, nasal sprays for medical purposes; pharmaceutical preparations for inhalers for the treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; ; probiotic preparations for medical and veterinary use; infant formula, namely, lactose free infant formula and hydrolyzed milk infant formula; additives for infant formula to prevent the development of allergies, namely, dietary supplements; food for babies; diagnostic testing materials for medical use, namely, diagnostic test patch for application to the skin for determining allergies; allergy and asthma testing kits, namely, diagnostic test patch for application to the skin for determining allergic reactions; none of the aforesaid goods for use in the cardiovascular field nor for use in continence management, but all solely for use in relation to allergy and asthma

16 Printed matter, namely, printed calendars and forms; printed instructional and teaching materials except apparatus in the field of allergy and asthma; printed magazines and periodicals in the field of allergy and asthma; printed questionnaires on medical issues relating to allergy and asthma; none of the aforesaid goods relating to the cardiovascular field nor for use in continence management, but all solely for use in relation to allergy and asthma

44 Medical services and medical healthcare services; medical consulting services, namely, counselling and information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases as well as atopic dermatitis, food allergy, and anaphylactic reactions; providing patient support relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases, atopic dermatitis, food allergy, and anaphylactic reactions, also electronically or digitally, including through a website with or without subscription, namely, medical consultations; providing medical information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases, atopic dermatitis, food allergy, and anaphylactic reactions, also electronically or digitally, including through a website; medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; all of the aforesaid services in relation to allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis, food allergy, and anaphylactic reactions; none of the aforesaid services in relation to the cardiovascular field nor in relation to continence management, but all in relation to allergy and asthma only

42 Scientific, technological, medical, and pharmacological research services and design relating thereto, namely, scientific research and technological research in the field of manufacturing processes, medical research, pharmaceutical research, pharmaceutical products development and new product design; scientific and medical laboratory services; medical and scientific research, namely, conducting clinical trials for others; computer services, namely, the creation of online communities for registered users to participate in discussions, and engage in social networking; providing a website featuring technology that enables consumers to form virtual communities, engage in social networking and share information regarding food, food components, and food products; all of the aforesaid services in relation to allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; statistical investigations and statistical studies in the fields of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy, namely, medical research; none of the aforesaid services in relation to the cardiovascular field nor in relation to continence management, but all in relation to allergy and asthma only

CLARIFY

Trademark Events

Jul 28, 2022

Sn Assigned For Sect 66a Appl From Ib

Jul 30, 2022

Limitation From Original Application Entered

Aug 1, 2022

New Application Office Supplied Data Entered

Aug 5, 2022

Application Filing Receipt Mailed

Nov 28, 2022

Assigned To Examiner

Nov 30, 2022

Non-Final Action Written

Dec 1, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Jan 30, 2023

Refusal Processed By Mpu

Jan 30, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Feb 21, 2023

Refusal Processed By Ib

Jul 31, 2023

Teas Response To Office Action Received

Jul 31, 2023

Correspondence Received In Law Office

Aug 1, 2023

Teas/Email Correspondence Entered

Sep 8, 2023

Suspension Letter Written

Sep 8, 2023

Letter Of Suspension E-Mailed

Sep 8, 2023

Notification Of Letter Of Suspension E-Mailed

Jan 3, 2024

Notification Of Possible Opposition Sent To Ib

Jan 3, 2024

Notification Of Possible Opposition Created, To Be Sent To Ib

Jan 21, 2024

Notification Of Possible Opposition - Processed By Ib

Mar 8, 2024

Report Completed Suspension Check Case Still Suspended

Jun 17, 2024

Divisional Request Received

Jun 17, 2024

Teas Request To Divide Received

Aug 12, 2024

Case Assigned To Intent To Use Paralegal

Aug 29, 2024

Divisional Processing Complete